CLB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Core Laboratories Inc (CLB) is not a strong buy at the moment for a beginner investor with a long-term horizon. The technical indicators are weak, options sentiment is neutral, and there are no significant positive catalysts or recent news to drive the stock higher. The company's financial performance shows modest revenue growth but declining net income and EPS, which raises concerns about profitability. Given the lack of strong signals or catalysts, holding off on buying is recommended.
The MACD is negative and expanding (-0.218), indicating bearish momentum. RSI at 22.547 is in the oversold zone but does not provide a clear reversal signal. Moving averages are converging, showing no strong trend. The stock is trading near its support level (S1: 17.229), but there is no confirmation of a rebound.
Revenue increased by 6.98% YoY in Q4 2025, and gross margin improved by 20.95% YoY.
The MACD and RSI indicate weak momentum, and there are no significant news or trading trends to act as a catalyst.
In Q4 2025, revenue increased to $138.26M (+6.98% YoY), but net income dropped to $7.08M (-4.34% YoY), and EPS declined to $0.15 (-6.25% YoY). Gross margin improved to 18.13% (+20.95% YoY), reflecting better operational efficiency but weaker profitability.
No data available for recent analyst ratings or price target changes.
